Results 161 to 170 of about 21,216 (279)

Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial [PDF]

, 2013
Hiroyu Hatano, Matthew C. Strain, Rebecca Scherzer, Peter Bacchetti, Deborah Wentworth, Rebecca Hoh, Jeffrey N. Martin, Joseph M. McCune, James D. Neaton, Russell P. Tracy, Priscilla Y. Hsue, Douglas D. Richman, Steven G. Deeks   +12 more
openalex   +1 more source

Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC‐UV [PDF]

, 2009
Stefania Notari, Chiara Tommasi, Emanuele Nicastri, Rita Bellagamba, Massimo Tempestilli, Leopoldo Paolo Pucillo, Pasquale Narciso, Paolo Ascenzi   +7 more
openalex   +1 more source

Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways

, 2009
Signe Fransen, Soumi Gupta, Robert M. Danovich, Daria J. Hazuda, Michael D. Miller, Marc Witmer, Christos J. Petropoulos, Wei Huang   +7 more
openalex   +1 more source

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV‐1‐infected patients with undetectable viremia [PDF]

, 2010
Carmen Garrido, Norma Rallón, Natalia Zahonero, Marisa López, Vincent Soriano, Carmen de Mendoza, José M. Benito   +6 more
openalex   +1 more source

HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma.

Journal of Pharmaceutical and Biomedical Analysis, 2020
Yi Zheng, R. Aboura, S. Boujaafar, Gabrielle Lui, D. Hirt, N. Bouazza, F. Foissac, J. Treluyer, S. Benaboud, I. Gana   +9 more
semanticscholar   +1 more source

Maraviroc and raltegravir [PDF]

British Journal of Clinical Pharmacology, 2009
Eline A, Dubois, Adam F, Cohen
openaire   +2 more sources

Use of once‐daily raltegravir‐based HAART in HIV‐infected injection drug users [PDF]

, 2010
HK Tossonian, JD Raffa, O Alenezi, Kevin W. Anderson, Sara Jassemi, K Wight, Stanley DeVlaming, Barbara R. Conway   +7 more
openalex   +1 more source

A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use

, 2021
Alexander Mills, Laurie Myers, Casey Raudenbush, David A. Vossen, Hedy Teppler, Yanna R. Miteva, Suzanne Seeley, Brenda Homony, Walter L. Straus   +8 more
openalex   +1 more source

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort

, 2009
Linda Wittkop, Dominique Breilh, Djennifer Da Silva, P. Duffau, P. Mercié, Isabelle Raymond‐Letron, Guerric Anies, Heloísa Junqueira Fleury, M C Saux, François Dabis, Catherine Fagard, Rodolphe Thiébaut, Bernard Masquelier, I. Pellegrin   +13 more
openalex   +2 more sources

Safety and efficacy of raltegravir in patients with HIV‐1 and hepatitis B and/or C virus coinfection [PDF]

, 2011
JK Rockstroh, Hedy Teppler, Jing Zhao, Peter Sklar, CM Harvey, KM Strohmaier, RY Leavitt, B‐YT Nguyen   +7 more
openalex   +1 more source